Related Experiment Video

Updated: Jun 6, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

Notch signaling in glioblastoma: a developmental drug target?

Maria Maddalena Lino1, Adrian Merlo, Jean-Louis Boulay

  • 1Department of Biomedicine, University Hospital Basel, Basel, Switzerland.

BMC Medicine
|November 17, 2010
PubMed

Insights

Malignant gliomas, like glioblastoma multiforme (GBM), require new treatments. Targeting Notch signaling pathways offers a promising therapeutic strategy for these devastating brain tumors.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer research

Background:

  • Malignant gliomas, including glioblastoma multiforme (GBM), have poor prognoses despite current treatments.
  • Conventional therapies offer limited survival benefits for patients with malignant gliomas.
  • Novel therapeutic strategies are crucial for improving patient outcomes.

Purpose of the Study:

  • To review the mechanisms of Notch signaling in the central nervous system.
  • To explore the role of Notch signaling in glioma development and progression.
  • To discuss the potential of targeting Notch signaling for glioblastoma multiforme (GBM) therapy.

Main Methods:

  • Literature review of Notch signaling pathways in normal and neoplastic central nervous system development.
  • Analysis of Notch signaling's involvement in glioma hallmarks like proliferation, stem cell regulation, hypoxia, and angiogenesis.
  • Discussion of therapeutic strategies targeting Notch signaling in glioblastoma.

Main Results:

  • Notch signaling is integral to central nervous system development and cancer stem cell regulation.
  • Notch signaling influences key glioblastoma features such as proliferation, hypoxia, and angiogenesis.
  • Its central role in glioma pathogenesis suggests it as a viable therapeutic target.

Conclusions:

  • Targeting Notch signaling presents a promising avenue for novel glioblastoma multiforme (GBM) therapies.
  • Understanding Notch pathway networking in gliomas is key to designing effective treatments.
  • Further research into Notch-targeted therapies could significantly improve outcomes for GBM patients.

More Related Videos

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...